Bleomycin + Fibrovein ( DrugBank: Bleomycin )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 279 | 巨大静脈奇形（頚部口腔咽頭びまん性病変） | 1 |
279. 巨大静脈奇形（頚部口腔咽頭びまん性病変）
臨床試験数 : 14 / 薬物数 : 24 - (DrugBank : 9) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 105
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01347294 (ClinicalTrials.gov) | August 2011 | 11/4/2011 | Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations | Compare the Effect of Bleomycin and Tetradecyl Sodium Sulphate in the Treatment of Venous Malformations | Venous Malformation | Drug: Bleomycin;Drug: Fibrovein;Drug: Bleomycin + Fibrovein | Oslo University Hospital | NULL | Recruiting | 12 Years | 80 Years | All | 126 | Phase 4 | Norway |